Volume : 11, Issue : 09, September – 2024
Title:
FORMULATION AND EVALUATION OF SUPPOSITORIES CONTAINING ANTI-FUNGAL DRUGS LOADED WITH NANOPARTICLES
Authors :
Deepika KG*, Dr Josephine Leno Jenita
Abstract :
Abstract:
The development of effective antifungal therapies remains a critical challenge in medical science, particularly for patients with localized fungal infections. This study focuses on the formulation and evaluation of suppositories containing antifungal drugs incorporated with nanoparticles to enhance therapeutic efficacy and bioavailability. The research involved the preparation of suppositories using a range of antifungal agents, such as ketoconazole and fluconazole, which were loaded onto nanoparticles to improve drug release and absorption. Various nanoparticle carriers, including liposomes and polymeric nanoparticles, were utilized to optimize drug delivery. The suppositories were formulated through a process of melting and molding, ensuring uniform distribution of the active ingredients. Comprehensive evaluations included physicochemical characterization, drug release studies, and antifungal efficacy tests. Results demonstrated that the incorporation of nanoparticles significantly improved the solubility and stability of the antifungal drugs, leading to enhanced bioavailability and prolonged release profiles. The antifungal activity of the nanoparticle-loaded suppositories was superior compared to traditional formulations, suggesting a promising approach for treating localized fungal infections. This study highlights the potential of nanoparticle-enhanced suppositories in advancing antifungal therapy, offering a targeted and efficient treatment modality for patients.
Cite This Article:
Please cite this article in press Deepika KG et al., Formulation And Evaluation Of Suppositories Containing Anti-Fungal Drugs Loaded With Nanoparticles, Indo Am. J. P. Sci, 2024; 11 (09).
Number of Downloads : 10
References:
1. Wiederhold NP. Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance. Vol. 68, Clinical Chemistry. Oxford University Press; 2022. p. 83–90.
2. Zhang TY, Chen YQ, Tan JC, Zhou JA, Chen WN, Jiang T, et al. Global fungal-host interactome mapping identifies host targets of candidalysin. Nat Commun [Internet]. 2024 Feb 27;15(1):1757. Available from: https://www.nature.com/articles/s41467-024-46141-x
3. D’enfert C, Kaune AK, Alaban LR, Chakraborty S, Cole N, Delavy M, et al. The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives. 2020; Available from: https://academic.oup.com/femsre/advance-article/doi/10.1093/femsre/fuaa060/6000215
4. Garber G. An Overview of Fungal Infections. Vol. 61, Drugs. 2001.
5. Pathogenesis of Fungal Infections in the Central Nervous System_ Host and Pathogen Factors in Neurotropism _ Current Fungal Infection Reports.
6. Prieto-Granada CN, Lobo AZC, Mihm MC. Skin Infections. In: Diagnostic Pathology of Infectious Disease. Elsevier; 2018. p. 542–647.
7. Reddy GKK, Padmavathi AR, Nancharaiah Y V. Fungal infections: Pathogenesis, antifungals and alternate treatment approaches. Vol. 3, Current Research in Microbial Sciences. Elsevier Ltd; 2022.
8. Duff M. Vaginitis.
9. Paladine HL, Desai UA. Vaginitis: Diagnosis and Treatment [Internet]. Vol. 97. 2018. Available from: www.aafp.org/afphttp://www.aafp.org/afp/2018/0301/p321-s1.html.
10. eschenbach1983. March 1983 – Volume 26 – Issue 1 : Clinical Obstetrics and Gynecology (lww.com)